Price movement over the last 24 hours
Acadia Healthcare Company Inc vs Aterian Inc — how do they compare? Acadia Healthcare Company Inc trades at $30.77 (market cap $2.94B), while Aterian Inc trades at $1.22 (market cap $13.25M). The key difference: Acadia Healthcare Company Inc is far larger — about 221.9× Aterian Inc's market cap, and Acadia Healthcare Company Inc is trading nearer its 52-week high, Aterian Inc nearer its low. Which is the better fit depends on your goals.
| ACHC | ATER | |
|---|---|---|
Market Cap | $2.94B | $13.25M |
Sector | Health | Consumer Cyclical |
52-Week High | $31.92 | $1.55 |
52-Week Low | $11.68 | $0.54 |
Enterprise Value | $5.45B | $13.83M |
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.
The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.
Aterian (ATER) trades at $1.24, down 3.12% today, with a bullish technical signal from moving averages. The company shows improving operational trends with three consecutive quarterly earnings beats, though it remains unprofitable with a -30.78% net margin. Recent news highlights a special stockholders meeting on July 10, 2026, to vote on proposals that could return $0.85–$1.14 per share.
Investment outlook is mixed: positive technical momentum and potential shareholder returns contrast with persistent losses and negative cash flow. Key risks include sustained unprofitability and high short interest growth of 57.7% in March 2026. Analysts are evenly split between Buy and Hold ratings, reflecting cautious optimism amid fundamental challenges.
Trailing returns across standard periods
Latest headlines on both assets
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →